Background and purpose: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder worldwide. Fatty liver is more common in patients with metabolic syndrome, obese people, and type 2 diabetic individuals. Liver FibroScan is a non-invasive method to evaluate the stiffness and fibrosis of the liver. This study aimed to investigate the findings of FibroScan; the level of liver enzymes, triglycerides, and cholesterol; and demographic characteristics of patients with fatty liver.

Materials and methods: In this descriptive cross-sectional study, 300 patients referred to the Gastroenterology and Liver Specialist Clinic in Sari City over a year (2017-18). The patients who were diagnosed with fatty liver according to ultrasound results were included after ruling out Wilson's disease, hemochromatosis, viral hepatitis, and autoimmune diseases. Demographic findings and laboratory profiles were recorded from the patients' files. The severity of liver steatosis and fibrosis was determined from FibroScan results. Data were analyzed in SPSS16 software. Mean and standard deviation were used to express the distribution of quantitative variables of the studied groups, and frequency and percentage were utilized to describe qualitative data. To compare quantitative data, an independent t-test was conducted, while qualitative variables were compared using the Chi-Square test.